期刊文献+

头孢吡肟对医院分离的革兰阴性杆菌的体外抗菌活性的四种方法学评价 被引量:1

Evaluation of four methods to detect in vitro antimicrobial activity of cefepime for Gram-negative isolates from hospital
下载PDF
导出
摘要 目的调查四川大学华西医院2004年9月-11月301株临床常见革兰阴性杆菌对第四代头孢菌素头孢吡肟的耐药状况,评价我院现采用的MICROSCAN细菌鉴定药敏系统中快速接种法的准确性。方法用琼脂稀释法、纸片扩散法、标准浊度法和MICROSCAN快速接种法测定头孢吡肟对301株细菌的体外抑菌活性。以琼脂稀释法为标准参考方法,比较其它三种方法与其一致性。结果琼脂稀释法测定301株革兰阴性杆菌对头孢吡肟的体外总敏感率为78.1%;纸片扩散法、标准浊度法和MICROSCAN快速接种法与标准参考方法的一致率分别为:99.0%、98.3%和95.3%。纸片扩散法、标准浊度法与琼脂稀释法无统计学差异,MICROSCAN快速接种法与琼脂稀释法有统计学差异。结论头孢吡肟对大部分临床常见革兰阴性杆菌具有良好的体外抗菌活性。纸片扩散法及标准浊度法结果准确性较高,我院现采用的MICROSCAN快速接种法的准确性有待进一步探讨。 Objective To investigate the antibiotics resistance pattern to cefepime of Gram-negative bacilli isolated from West China Hospital of Sichuan University during September-November, 2004, and to evaluate the accuracy of prompt inoculation procedure of MICROSCAN Walkaway bacterial identification and susceptibility system. Method We collected 301 Gram-negative isolates and tested the susceptibility of bacteria to cefepime by four methods: Kirby-Bauer (KB) method, standard agar dilution, MICROSCAN turbidity standard method and MICROSCAN prompt method respectively, and compared the consistency of other three method with standard agar dilution method. Result The total susceptibility rate of cefepime was 78. 1% via standard agar dilution method. The consistent rate of KB method, MICROSCAN turbidity standard method and MICROSCAN prompt method to standard agar dilution method was 99.0%, 98.3% and 95. 3% respectively. There were no significant difference between them. Conclusion Cefepime has a powerful in vitro antimlcrobial activity to most clinical Gram-negative bacilli. The accuracy of KB method and MICROSCAN turbidity standard method was vertified. But the accuracy of MICROSCAN prompt method needed the further study.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2007年第2期100-103,共4页 Chinese Journal of Antibiotics
关键词 头孢吡肟 KB法 琼脂稀释法 MICROSCAN标准浊度法 MICROSCAN快速接种法 Cefepime KB method Standard agar dilution MICRCSCAN turbidity standard method MICROSCAN prompt method
  • 相关文献

参考文献11

  • 1马越,李景云,胡昌勤,金少鸿,国家细菌耐药性监测网.头孢吡肟等抗生素对革兰阴性杆菌体外敏感性连续四年耐药性监测分析[J].中华检验医学杂志,2004,27(11):747-751. 被引量:22
  • 2ghao J J. Yang A Y, Rogers J D. Effects of liquid chromatography mobile phase buffer contents on the ionization and fragmentation of analysis in liquid chromatographic/ionspray tandem mass spectrometric determination [J]. dMass Spectrom, 2002,37: 421
  • 3Jones R N, Biedenbach D J, Gales A C. Sustained activity and spectrum of selected extented-speetrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-produeing Klebslella spp. : report from the SENTRY antimicrobial surveillance program (USA, 1997 -2000) [J]. Int d Antimicrob Agents,2003,21(1):1
  • 4中华人民共和国卫生部医政司.全国临床检验操作规程(第二版)[M].南京:东南大学出版社,1997..
  • 5Performance Standards for Antimierobial Susceptibility[S], Fourteenth Informational Supllement Clinical and Laboratory Standards Institute,2004 : 96
  • 6Cappelletly D M. Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model [J]. Antimicrob Agents Chemother, 1999,43(1) : 129
  • 7熊薇,张文池,陈如,刘守桂.头孢类抗生素对临床常见革兰阴性杆菌体外抗菌活性的比较研究[J].中华医院感染学杂志,2001,11(4):251-253. 被引量:20
  • 8艾效曼,张秀珍.3年2436株临床分离革兰阴性杆菌对头孢吡肟耐药趋势观察[J].中国临床药理学杂志,2003,19(1):23-25. 被引量:8
  • 9Szabo D, Mathe A, Filetoth E, et al. In vitro and in vivo activities of amikaein cefepime, amlkacin plus eefepime, and imipenem against an SHV-5 extended-spectrum betalactamase-produeing Klebsiella pneumoniae strain [J]. Antimicrob Agents Chemother, 2001,45 (4):1287
  • 10Thomson K S, Moland E S. Cefepime, piperacillin,tazobactam, and the inoculum effect in test with extend-spectrum β-lactamase producing Enterobacteiaceae [J].Antimicrob Agents Chemother, 2001,45 (12) : 3497

二级参考文献20

  • 1汪复.β-内酰胺类抗生素临床应用进展[J].中国新药杂志,1996,5(2):81-85. 被引量:22
  • 2[3]Steward CD, Rasheed J K, Hubert SK. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extendedspectrum beta-lactamase detection methods. J Clin Microbiol.2001 ;39: 2864~2872.
  • 3[4]Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol, 2000;38:1791 ~ 1796.
  • 4[5]National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing.Ninth Informational Supplement. NCCLS Documents M 100-S9.Pennsylvania: NCCLS, 1999, 17~99.
  • 5Vandepitte J, Engbaek K, Piot P, et al. Basic Laboratory Procedures in Clinical Bacteriology [M]. Geneva: World Health Organization, 1991.
  • 6Ferraro M J. Craig W A, Dudley M N. et al. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Seventh Edition. National Committee for Clinical Laboratory Standards, M2-A7 (Vol. 20, No. 1), January 2000.
  • 7Ferraro M J, Craig W A, Dudley M N, et al. Performance Standards for Antimicrobial Disk Susceptibility Tests; Twelfth Informational Supplement. National Committee for Clinical Laboratory Standards, M100-S2(Vol. 22, No. 1), January 2002.
  • 8WHONET5 Microbiology Laboratory Database Software, World Health Organization, Department of Communicable Disease Surveillance and Response, 1999.
  • 9O'Brien T F, Eskildsen M A. Stelling J. Using Internet Discussion of Antimicrobial Susceptibility Database for Continuos Quality Improvement of the Testing and Management of Antimicrobial Resistance [J]. Clinic Infect Dis ,2001,33(Suppl 3) :S118.
  • 10Murray PR , Baron EJ, Pfaller MA, et al. Manual of Clinical microbiology 7th ed. American society for microbiology, Washington, D.C.1999, 262-560.

共引文献51

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部